GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
376
c/compounding·posted 2 years ago by u/liver_enzyme_liz

[Question] Poland — has anyone got a straight answer on 503B

Question Receipts ×8

Something I noticed reading old threads that I have not seen said out loud.

The advice on 503B in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.

I have listed what I think the current consensus is below. Correct me — that is the point of posting it.

538 up / 162 down77% upvoted19 commentsid jgcvah15 Jun 2024

19 comments

16 in this archive, depth 5

best — the order this archive was captured in

u/ferran_mensah55 points·2 years ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/fatima_kowalski28 points·2 years ago·edited

the Germany situation is different from the US, different regulations

replysharereportpermalink
u/hassan_chowdhury25 points·2 years ago

Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.

replysharereportpermalink
u/lukas_vermeulen13 points·2 years ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/maren_sorensen-13 points·2 years ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/amara_kuipers1 point·2 years ago

shortage list status is state board, check the actual list

replysharereportpermalink
u/honest_syringe_20251 point·2 years ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
[deleted]1 point·2 years ago

[deleted]

replysharereportpermalink
u/yannick_barros-18 points·2 years ago

the 503A/503B distinction is load-bearing, do not blur it

replysharereportpermalink
u/honest_syringe1 point·2 years ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/ffmi_watcher1 point·2 years ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/liver_enzyme_lizOP1 point·2 years ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/mateusz_adebayo7 points·2 years ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/bruno_dumitru6 points·2 years ago·edited

Which state? Rules vary.

replysharereportpermalink
u/amara_kuipers2 points·2 years ago

You have restated the marketing copy. What is the actual substance here.

replysharereportpermalink
u/liver_enzyme_lizOP1 point·2 years ago

state board rules differ, say which state

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →